Avita Medical is a medical device company that provides a unique approach to skin regeneration



The Company

Avita Medical is a medical device company that transforms lives through its unique and innovative skin regeneration solutions. We are a publicly listed, global medical technology company trading on the Australian Stock Exchange (ASX:AVH) and OTC Markets (OTCQX:AVMXY). We develop and distribute highly innovative regenerative products.

Our patented and proprietary collection and application technology provides innovative treatment solutions derived from a patient’s own skin to treat a wide range of wounds, scars and skin defects. Our devices create a Regenerative Epithelial Suspension (RES™) – an autologous suspension comprised of the cells and wound healing factors necessary to regenerate natural healthy skin.

Avita’s regenerative product portfolio includes ReCell® for burns aimed at plastic reconstructive procedures, ReGenerCell™ for chronic wounds and ReNovaCell™ for the restoration of pigmentation.

Read more



The Company

Avita Medical is a medical device company that transforms lives through its unique and innovative skin regeneration solutions. We are a publicly listed, global medical technology company trading on the Australian Stock Exchange (ASX:AVH) and OTC Markets (OTCQX:AVMXY). We develop and distribute highly innovative regenerative products.

Read more


7,585

Procedures

32

Market Approvals

64

Published Papers

47%

reduction in hospital stay20

38%

reduction in donor skin21

ReCell® is a medical device that enables medical professionals to collect cells from a small sample of a patient’s own skin to create a suspension that can regenerate wounds caused by burns.

55%

reduction in wound area in 4 weeks2

33%

pain reduction in one week7

ReGenerCell™ is a medical device that allows medical professionals to swiftly create a suspension of skin cells that can trigger healing in chronic wounds, such as venous leg ulcers and diabetic foot ulcers.

78%

re-pigmentation2

reduced

healing time, risk of infection and scarring4,6,7

ReNovaCell™ is a medical device that delivers a skin cell suspension for treating aesthetic applications: restoring pigmentation, and improving the appearance of scars, sun-damaged skin, wrinkles and lesions.

Twitter

follow

Thursday, April 6th, 2017 at 10:29am
Adam Kelliher, CEO, presents Avita's upcoming commercial and clinical milestones at the 16th Annual Needham Healthcare Conference, NYC. https://t.co/T3UFliUBeh AvitaMedical photo
1
1
Wednesday, March 29th, 2017 at 10:51am
A ReCell lecture was a highlight from the National Key Discipline Training Plan: Third Wound New Treatment Training Course, held in Beijing. https://t.co/Y6HsdfBWd7 AvitaMedical photo
1
Saturday, March 25th, 2017 at 2:23am
Great discussion and questions on ReCell during ABA correlative session #ameriburn2017
1
Friday, March 24th, 2017 at 10:19am
Adam Kelliher, CEO to present at 16th Annual Needham Healthcare Conference, 4 April, NYC. Register for webcast - https://t.co/x3QxChIZuM
1
2

Facebook

follow

Avita Medical
Avita Medical in New York, New York.Thursday, April 6th, 2017 at 1:32pm

Adam Kelliher, CEO, presents Avita's upcoming commercial and clinical milestones at the 16th Annual Needham Healthcare Conference, New York City.

Avita Medical
Avita Medical added 4 new photos.Wednesday, March 29th, 2017 at 1:41pm

A ReCell lecture was one of the highlights from the National Key Discipline Training Plan: Third Wound New Treatment Training Course, hosted by the Jishuitan Hospital, Beijing, China. The audience of 50 surgeons from major hospitals across China also viewed a live cross to a...

Share Price

Last Trade: Last Trade: 1.54
High: High: 1.54
Low: Low: 1.5
Close: Close: 1.56
Volume: Volume: 21650
Prices are delayed by 20 minutes